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Abstract: Potential applications of carbon nanotubes have attracted many researchers in the 
field of drug delivery systems. In this study, multiwalled carbon nanotubes (MWNTs) were 
first functionalized using hyperbranched poly citric acid (PCA) to improve their hydrophilicity 
and functionality. Then, paclitaxel (PTX), a potent anticancer agent, was conjugated to the 
carboxyl functional groups of poly citric acid via a cleavable ester bond to obtain a MWNT-g-PCA-
PTX conjugate. Drug content of the conjugate was about 38% (w/w). The particle size of 
MWNT-g-PCA and MWNT-g-PCA-PTX was approximately 125 and 200 nm, respectively. 
Atomic force microscopy and transmission electron microscopy images showed a curved shape 
for MWNT-g-PCA and MWNT-g-PCA-PTX, which was in contrast with the straight or linear 
conformation expected from carbon nanotubes. It seems that the high hydrophilicity of poly 
citric acid and high hydrophobicity of MWNTs led to conformational changes from a linear state 
to a curved state. Paclitaxel can be released from the MWNT-g-PCA-PTX conjugates faster at 
pH 6.8 and 5.0 than at pH 7.4, which was suitable for the release of the drug in tumor tissues 
and tumor cells. In vitro cytotoxicity studies were evaluated in the A549 and SKOV3 cell lines. 
MWNT-g-PCA had an insignificant cytotoxic effect on both cell lines. MWNT-g-PCA-PTX 
had more of a cytotoxic effect than the free drug over a shorter incubation time (eg, 24 hours 
versus 48 hours), which suggests improved cell penetration of MWNT-g-PCA-PTX. Therefore, 
paclitaxel conjugated to MWNT-g-PCA is promising for cancer therapeutics.
Keywords: multiwalled carbon nanotubes, functionalization, anticancer, drug delivery, 
nanoparticles
Introduction
Carbon nanotubes, discovered in 1991 by the Japanese electron microscopist Sumio 
Iijima, opened up new opportunities in the field of nanotechnology and nanoscience.1–3 
The interesting properties of carbon nanotubes, such as stability, inertness, and 
higher surface area-to-volume ratio than spheres (providing high loading capacity for 
guest molecules), suggest the potential utility of these materials as carriers in drug 
delivery systems requiring higher loadings of therapeutic agents.4–6 The application 
of carbon nanotubes in drug delivery systems was apparent immediately after the 
first demonstration of the capacity of these materials to penetrate into cells.7 Several 
in vitro studies have demonstrated that carbon nanotubes can effectively transport 
various molecules including drugs, peptides, and proteins into cells.8–13
High hydrophobicity, low functionality, and the large size of pure carbon 
nanotubes limit their biological applications. Therefore, modification of carbon 
nanotubes through covalent or noncovalent functionalization of their external walls International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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is a key step for biomedical applications because a wide 
variety of active molecules can be linked to a functionalized 
carbon nanotube.14–18 The ultra high surface area of these 
macromolecules is appropriate for efficient loading of 
chemotherapy drugs.11,19 Although the various functionaliza-
tions of carbon nanotubes have been successfully achieved, 
only a few examples of delivery of small molecules (antiviral, 
antibacterial, and anticancer agents) using functionalized 
carbon nanotubes have been reported.16,20,21
Polyethylene glycol has been popular as a means of 
functionalization of carbon nanotubes in drug delivery 
systems.22,23 Due to the hydrophilicity of polyethylene 
glycol, this polymer is used to prepare stealth nanoparticles 
to escape reticuloendothelial systems. The long circulation 
time facilitates passive targeting to the cancer cells through 
the enhanced permeability and retention effect of tumor 
blood vessels.24 Liu et al loaded doxorubicin onto pegylated 
single-walled carbon nanotubes11 and also covalently 
conjugated paclitaxel to branched polyethylene glycol 
segments which were adsorbed on the side walls of carbon 
nanotubes.25 However, polyethylene glycol with limited 
arms was commonly used for functionalization of carbon 
nanotubes to conjugate to other molecules for drug delivery 
systems. In this study, hyperbranched poly citric acid (PCA) 
with a high capacity for conjugation to drug molecules 
was used for the functionalization of multiwalled carbon 
nanotubes (MWNTs).
The shape and size of nanoparticles are two critical 
factors that affect the toxicity and efficiency of drug delivery 
systems. However, the shape, size, and conformation of the 
drug delivery systems based on carbon nanotubes have not 
been investigated in depth.
In this report, we propose a novel drug delivery system 
for cancer chemotherapy based on multiwalled carbon 
nanotubes functionalized with hyperbranched poly citric 
acid (MWNT-g-PCA) and conjugated to the commonly 
used potent chemotherapy drug, paclitaxel (PTX), to 
produce a MWNT-g-PCA-PTX conjugate. As described 
previously, these carbon nanotubes can be taken up by 
cells through endocytosis, where the cleavable ester bond 
between paclitaxel and poly citric acid is hydrolyzed and 
paclitaxel is released into the cytoplasm. Thus, we deter-
mined the morphology, size, and cytotoxicity of MWNT-
g-PCA-PTX conjugates. We found that the conformation 
of MWNT-g-PCA changes from a straight to curved nano-
structure. In addition, cytotoxicity studies revealed that the 
MWNT-g-PCA-PTX conjugate increased the cytotoxicity 
of the drug.
Methods
Functionalization of MWNTs  
with poly citric acid
Multiwalled carbon nanotubes (number of walls 3–15, outer 
diameter 5–20 nm, length 1–10 µm) were purchased from 
Plasmachem GmbH, Berlin, Germany. MWNT-g-PCA 
was synthesized according to procedures reported in the 
literature.26,27 Briefly, 1 g of MWNTs was mixed with 20 mL 
of concentrated HNO3 and H2SO4 (1:3 ratio), and the mixture 
was sonicated for 30 minutes and refluxed for 24 hours at 
100°C. The resulting black mixture was then diluted with 1 L 
of distilled water,   filtered, and washed with deionized water 
to adjust the pH to 6. The filtrate was dried in a vacuum oven 
for 24 hours at 40°C. Then, 0.1 g of oxidized MWNTs and 
2.5 g of   monohydrated citric acid was added to a polymeriza-
tion ampoule equipped with a magnetic stirrer and a vacuum 
inlet. The mixture was heated to 100°C while stirring for 
30   minutes. After   removing water via the vacuum inlet, 
the reaction   temperature was   gradually increased to 140°C 
over four hours, while the dynamic vacuum was operated 
at proper intervals. The   product was cooled and then dis-
solved in tetrahydrofuran. Free citric acid was precipitated 
in cyclohexane.
Synthesis of MWNT-g-PcA-PTX 
conjugate
MWNT-g-PCA (50 mg), N-(3-dimethylamino propyl)- 
N-ethylcarbodiimide hydrochloride (EDC) (23 mg, 
0.12 mmol) and 4-(dimethylamino) pyridine (DMAP)
(15 mg, 0.12 mmol) were   dissolved in 5 mL of anhydrous 
dimethylformamide. The mixture was then stirred at 0°C 
for 30 minutes. Anhydrous   dimethylformamide (5 mL) 
containing paclitaxel (50 mg, 0.06 mmol) was then added to 
the mixture and stirred for 24 hours at 0°C. Precipitate was 
filtered out and the filtrate was dialyzed (molecular weight 
cutoff 1200 Da, Sigma-Aldrich Corp St. Louis, MO) against 
dimethylformamide overnight to remove untreated materials. 
The dialyzed solution was then dried under nitrogen stream 
for four hours. The reaction process between paclitaxel and 
activated MWNT-g-PCA was carried out at different times 
(24, 48, and 72 hours) and at different drug to carrier ratios 
(0.1/1, 0.5/1, 1/1, and 2/1 w/w) to obtain the optimum drug 
content and reaction yield.
characterization techniques
The CNT-g-PCA-PTX conjugate was characterized using 
infrared, 1H nuclear magnetic resonance (NMR), 13C NMR, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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differential scanning calorimetry, dynamic light scattering, 
and microscopic techniques as follows: infrared (Perkin-Elmer 
Spectrum GX, Waltham, MA) was used to analyze the changes 
in the surface chemical bonding and structure, using KBr 
discs of each sample in the frequency range of 4000–400 cm-1. 
1H NMR spectra were recorded in dimethyl sulfoxide   solution 
on Bruker DRX 500 (500 mHz [Bruker Corporation, Billerica, 
MA]) apparatus with the solvent proton signal for reference. 
13C NMR spectra were recorded on the same instrument using 
the solvent carbon signal as a reference. Differential scanning 
calorimetry was used to determine the thermal behavior of 
the conjugated nanotubes. Differential scanning calorimetry 
analysis was   performed with a Mettler DSC 823-e (Mettler 
Toledo GmbH,   Greifensee, Switzerland) instrument using 
Mettler Stare software version 9.x. Indium was used to cali-
brate the instrument. Samples weighing approximately 10 mg 
were heated in a hermetically sealed aluminum pan at a rate 
of 10°C/min in a temperature range of 25–400°C under a 
nitrogen atmosphere.
Particle size and polydispersity of the MWNT-g-PCA 
and MWNT-g-PCA-PTX conjugates were determined 
by dynamic light scattering (Zetasizer Nano-ZS Malvern 
Instruments, Malvern, UK), fitted with particle size analysis 
software (Dispersion Technology software v 4.2) at 25°C.
The shape and surface morphology of the conjugate 
nanostructures were evaluated by atomic force microscopy 
(Dualscope C-21, DME, Copenhagen, Denmark, with DME-
SPM v2.1.1.2 software) and transmission electron micros-
copy (Philips CN10, [Philips, Eindhoven, the Netherlands] 
etherlands). Atomic force microscopy was performed in air 
under ambient conditions, and transmission electron micros-
copy analysis was performed at 100 kV .
Paclitaxel content of the conjugate
The amount of paclitaxel loaded onto MWNT-g-PCA-PTX 
was quantified by an indirect method28 whereby free pacli-
taxel after the reaction with MWNT-g-PCA that accumulated 
in the dialysis medium was analyzed. In this way, the amount 
of conjugated paclitaxel to the MWNT-g-PCA was estimated 
according to the initial amount of drug. This amount was 
presented as mass of drug in the conjugate according to the 
following equation. For high-pressure liquid chromatography 
analysis, samples (20 µL) were injected into a Knauer system 
(Model k 1001, WellChrom, [Dr. Ing. Herbert Knauer GmbH, 
Berlin, Germany]) equipped with an ultraviolet detector (UV 
Detector 2500). Isocratic chromatography was performed 
on a C-18 column (4.6 mm × 25 cm) with 5 µm packing 
(Knauer) using acetonitrile/water (60:40 v/v) as a mobile 
phase. Paclitaxel was detected at 227 nm. Drug content was 
calculated by the following equation:
 
DrugcontentW /W
Massof druginconjugate
Massof conjugate
(% ) =× 100
In vitro drug release
The pattern of drug release from the MWNT-g-PCA nano-
structures was studied in deionized water and phosphate 
buffers at pH 5.0, 6.8, and 7.4 containing 0.1% (w/v) Tween 
80 as medium.29 The correct amount of MWNT-g-PCA-PTX 
(containing 1 mg of paclitaxel) dispersed in 10 mL of media 
containing 0.1% (w/v) Tween 80 was placed in a dialysis 
bag immersed in 100 mL of the release media, and was then 
placed in an incubator shaker set at 100 rpm and 37°C. At 
predetermined time intervals, 10 mL of the release medium 
was removed and replaced with fresh medium. Samples were 
diluted with acetonitrile (1:1 ratio) and the paclitaxel released 
was determined by high-pressure liquid chromatography as 
described.
In vitro cytotoxicity
The cytotoxicity of MWNT-g-PCA-PTX, MWNT-g-PCA, 
and free paclitaxel was assessed by standard MTT assay. 
SKOV3 ovary cancer cells and A549 lung cancer cells were 
cultured in RPMI-1640 medium supplemented with 10% fetal 
bovine serum and 1% penicillin-streptomycin at 37°C in a 
humidified incubator with 5% CO2. Cells in the exponential 
growth phase were seeded in 96-well plates (Nunc, Denmark) 
at a density of 1 × 104 viable cells/well. After overnight 
incubation, cells were exposed to different concentrations of 
free paclitaxel, MWNT-g-PCA-PTX, and MWNT-g-PCA in 
dimethyl sulfoxide at 37°C for predetermined times under 
standard cell culture conditions. At designated time inter-
vals, 20 µL of MTT (5 mg/mL) was added to each well and 
incubated for 3–4 hours. The formazan crystals in each well 
were then dissolved in 100 µL of dimethyl sulfoxide. The 
absorbance of each well was measured with a microplate 
reader (Anthos 2020, [Anthos Labtec Instruments GmbH, 
Salzburg, Austria]) at 570 nm against 690 nm. The percent-
age of cell viability was calculated according to the following 
equation:
 
Cellviability
Absn moft reatedgroup
Absn mofc ontrolgrou
% =
570
570 p p
×100
In all the cytotoxicity assays, cell treatments were 
assessed in triplicate and the results of three independent 
experiments were reported (n = 3). The toxicity of the International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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MWNT-g-PCA-PTX and free paclitaxel was also expressed 
as the inhibitory concentration at which 50% of cell growth 
inhibition was obtained (IC50).
Statistical analysis
Statistical analysis was performed using the Student’s 
t-test for the two groups. All results were expressed as the 
mean ± standard deviation (SD). A probability (P) of less 
than 0.05 was considered to be statistically significant.
Results
Synthesis of MWNT-g-PcA-PTX 
conjugate and structural characterization
Paclitaxel was conjugated to the carboxyl functional 
groups of the poly citric acid branches on the surface of 
MWNTs via a cleavable ester bond, forming a MWNT-g-PCA-
PTX conjugate (Figure 1). The ester used in this study 
was prepared by the “active ester approach” method in 
N, N-dimethylformamide, using aminopropylcarbodiimide 
as the condensing agent and 4-dimethylaminopyridine as the 
base. The unconjugated paclitaxel was removed   thoroughly 
from the MWNT-g-PCA-PTX solution by dialysis. 
The conjugation reaction of paclitaxel to MWNT-g-PCA was 
optimized for time, temperature, and drug/MWNT-g-PCA 
ratios. The reaction was completed in 24 hours and the 
optimal drug/MWNT-g-PCA ratio was 1/1 (w/w). In these 
conditions, the percentage of loaded drug or loading capacity 
was 38% ± 7% and the reaction yield was 25% ± 2% (n = 3). 
When the drug/MWNT-g-PCA ratio was increased to 2:1, the 
drug content and reaction yield were slightly increased to 
40% ± 6% and 30% ± 4%, respectively. The limited loading 
capacity for paclitaxel at a higher drug:carrier ratio may be 
related to high steric hindrance of paclitaxel (the infrared 
spectrum of samples were shown in supplementary data, 
Figure S1).
In the infrared spectrum of MWNT-g-PCA (see 
supplementary data, Figure S1-b), broad absorbance bands 
at 3550–2400 cm−1 were assigned to the hydroxyl groups of 
poly citric acid branches grafted on the surface of MWNTs, 
while a relatively broad absorbance band at 1750–1700 cm−1 
corresponded to the carbonyl groups of oxidized MWNTs 
and acidic and esteric carbonyl groups of grafted poly c  itric 
acid. The infrared spectrum of paclitaxel (Figure S1-c) 
showed two characteristic bands at 1736 cm−1 and 1644 cm−1, 
which were each assigned to its carbonyl groups and the 
C = O bonds of amide group, respectively. These two peaks 
appeared in the infrared spectrum of the MWNT-g-PCA-
PTX conjugate (Figure S1-d). The absorbance bands at 
3400–3500 cm−1   corresponded to the hydroxyl groups of 
paclitaxel (Figure S1-c), and broad absorbance bands of 
hydroxyl groups of poly citric acid branches (Figure S1-b) 
were transformed into a single band at 3380 cm−1 in the 
MWNT-g-PCA-PTX conjugate (Figure S1-d). These findings 
confirmed the reaction between paclitaxel and poly citric acid 
branches of MWNT-g-PCA through esteric bonds.
Conjugation of paclitaxel molecules to the surface of 
MWNTs by poly citric acid spacers could easily be proven 
through comparison of the 1H and 13C NMR spectra of pacli-
taxel, MWNT-g-poly citric acid, and MWNT-g-PCA-PTX 
(supplementary data Figure S2, S3). In the 1H NMR spectra 
of MWNT-g-PCA-PTX (Figure S2-c) conjugate, signals of 
poly citric acid branches appeared between 2.6–3.6 ppm, 
as could also be seen in the 1H NMR spectra of MWNT-g-
PCA (Figure S2-b). In the 13C NMR of MWNT-g-PCA-PTX 
conjugate (Figure S3-c), the appearance of a new signal at 
206 ppm (in comparison with MWNT-g-PCA and pacli-
taxel) showed attachment of the paclitaxel molecules to 
the carboxyl functional groups of poly citric acid branches 
through ester bonds.
The thermal behavior of the conjugated nanotubes 
was investigated using differential scanning calorimetry 
(Figure 2). The differential scanning calorimetry curve of 
paclitaxel (Figure 2B) showed an endothermic peak at 220°C 
and an exothermic peak at 242°C which were assigned to its 
melting and degradation points, respectively. The differential 
scanning calorimetry curve of MWNT-g-PCA (Figure 2A) 
showed two endothermic peaks about 100–140°C and 
180–250°C. The first endothermic peak was attributed to the 
loss of water and decomposition of poly citric acid branches. 
The second peak indicated the collapse of MWNTs. The 
differential scanning calorimetry curve of MWNT-g-PCA-
PTX conjugate (Figure 2D) showed a completely different 
pattern in comparison with paclitaxel and MWNT-g-PCA as 
MWNT-g-PCAM WNT-g-PCA-PTX
Figure 1 Scheme of conjugated paclitaxel to MWNT-g-PcA. 
Abbreviations: MWNT, multiwalled carbon nanotube; PcA, poly citric acid.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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precursors. The differential scanning calorimetry curve of the 
MWNT-g-PCA-PTX conjugate contained a large number of 
endothermic peaks starting at 180°C. The different pattern for 
the differential scanning calorimetry thermogram of MWNT-
g-PCA-PRX referred to the nonhomogeneous structure and 
several objects that were conjugated together in a core shell-
like hybrid nanomaterial. To emphasize that paclitaxel is not 
absorbed on MWNT-g-PCA physically but rather conjugated 
to it, a differential scanning calorimetry thermogram of a 
physical mixture of MWNT-g-PCA and paclitaxel (1:1 w/w) 
was compared with the MWNT-g-PCA-PTX conjugate. 
As can be seen in Figure 2C and Figure 2D, there is a big 
difference between the two thermograms. In the differential 
scanning calorimetry curve of the MWNT-g-PCA-PTX 
conjugate (Figure 2D), peaks of parent molecules (pacli-
taxel and MWNT-g-PCA) disappeared and a new profile 
was obtained, while in the physical mixture of MWNT-g-
PCA and paclitaxel (Figure 2C) large endothermic peaks 
of MWNT-g-PCA covered the related peaks of paclitaxel. 
These results demonstrated that paclitaxel is conjugated to 
MWNT-g-PCA covalently.
Particle size and polydispersity
Size and polydispersity of the conjugated nanotubes was 
evaluated using dynamic laser light scattering. The size 
of MWNT-g-PCA in water was about 125 nm and that of 
MWNT-g-PCA-PTX was about 207 nm (supplementary 
data Figure S4), suggesting no significant aggregation of the 
MWNT-g-PCA after conjugation of the hydrophobic drug 
molecules. In order to confirm that dynamic light scattering 
produces the morphology and size of conjugated nanotubes, 
the nanotubes were further investigated using atomic force 
microscopy and transmission electron microscopy.
Shape and surface morphology
Figure 3 shows atomic force microscopy images of oxi-
dized MWNTs, MWNT-g-PCA, and MWNT-g-PCA-PTX 
dispersed on the surface of mica wafers. The atomic force 
microscopy image of oxidized MWNTs (Figure 3A) showed 
that the carbon nanotubes were in their extended conforma-
tion as linear or fiber shapes. They each had a length of 
several micrometers and a height of approximately 10 nm. 
Interestingly, atomic force microscopy images of MWNT-g-
PCA (Figures 3B–D) did not show any linear or filamentous 
objects. It appears that the conjugated nanotubes were either 
in their closed or packed conformation with a disc-like 
  morphology. The height and width of these nanostructures 
were 40–50 nm and 150 nm, respectively. Phase contrast 
imaging (Figure 3C and 3D) showed one phase for this 
hybrid material, confirming that the surface of the MWNT 
was covered by poly citric acid branches.
Topology images of the MWNT-g-PCA-PTX (Figure 3E) 
showed spherical nanostructures with a height and width of 
about 350 nm. However, phase contrast images of MWNT-
g-PCA-PTX (Figure 3F and 3G) showed that spherical 
nanostructures observed in their topology images consisted 
of two or more self-assembled disc-like objects, with a size 
of approximately 100–130 nm.
Transmission electron microscopy images confirm 
the results of the atomic force microscopy observations. 
  Figure 4 shows transmission electron microscopy images 
of MWNT-g-PCA-PTX. As shown, these particles are self-
assembling toward spherical nanostructures, and no linear 
conformation for MWNTs could be seen.
In vitro drug release
Due to the variability of the pH from 7.4 in extracellular 
parts of normal tissues, ie, 6.8 in tumor tissues and 5.0 in 
endosomes and lysosomes,30 the release profiles of paclitaxel 
from the MWNT-g-PCA-PTX conjugates were evaluated at 
all the aforementioned pHs in the presence of 0.1% (w/w) 
Tween 80 for maintaining sink conditions. At sink condi-
tions, the theoretical highest concentration of the drug in 
the medium is well below the 15% drug aqueous solubility. 
The aqueous solubility of paclitaxel is very low, and addition 
mw
20
10
0
−10
−20
−30
−40
−50
−60
05 10 15
150 200 250 300 350 400
0C
35 min
C
B
D
A
30 25 20
100 50
Figure  2  Differential  scanning  calorimetry  thermograms  of  A)  MWNT-g-PcA, 
B) paclitaxel, C) physical mixture of MWNT-g-PcA and paclitaxel (1:1 w/w), and 
D) MWNT-g-PcA-PTX conjugates containing 40% w/w paclitaxel. 
Abbreviations: MWNT, multiwalled carbon nanotube; PcA, poly citric acid; PTX, 
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of surfactants to the release medium increases its solubility. 
Therefore, the sink condition was maintained by the addition 
of Tween 80 and the frequent replacement of fresh buffer 
during the experiment.
As shown in Figure 5, hydrolysis of ester bonds to release 
paclitaxel in deionized water was significantly slower than 
in phosphate-buffered solutions. The release of paclitaxel 
from the MWNT-g-PCA-PTX conjugates at pH 6.8 and 5.0 
was higher than at pH 7.4 (12.5% and 22.2% at pH 6.8 and 
5.0, respectively, compared with 10.2% at pH 7.4), which 
was suitable for the release of the drug in tumor tissues and 
tumor cells.
In vitro cytotoxicity
To verify whether the paclitaxel-conjugated nanotubes were 
pharmacologically active, in vitro cytotoxicity tests were 
conducted on SKOV3 ovary and A549 lung cancer cell lines. 
Figure 6 shows the cell viability of SKOV3 and A549 cells 
incubated with paclitaxel and MWNT-g-PCA-PTX for 
24 hours and 48 hours. MWNT-g-PCA-PTX   exhibited 
similar cytotoxicity as paclitaxel at shorter incubation 
times. As shown in Figure 6A at 40 nM concentration, the 
  cytotoxicity of MWNT-g-PCA-PTX at 24 hours was equal to 
the effect of paclitaxel at 48 hours. In addition, at a compa-
rable incubation time, MWNT-g-PCA-PTX showed a higher 
cytotoxic effect than paclitaxel (P , 0.05). For instance, at 
24 hours, the   cytotoxicity of MWNT-g-PCA-PTX containing 
40 nM of paclitaxel was approximately 20% greater than the 
effect of 40 nM of free paclitaxel in A549 cells (Figure 6A). 
  Therefore, the MWNT-g-PCA-PTX conjugates exhibited 
more   cytotoxicity when compared with free paclitaxel at 
shorter incubation times. The same   observations were made 
in the SKOV3 cell line (Figure 6B). These results could be 
related to the increased cell penetration of paclitaxel when 
  conjugated to the MWNT-g-PCA. Extending the exposure 
time of paclitaxel and MWNT-g-PCA-PTX to 96 and 
120 hours provided sufficient time for the penetration of 
free paclitaxel. Thus, after 96 hours, the MWNT-g-PCA-
PTX exhibited similar toxicity patterns as free paclitaxel 
in both cell lines (Figure 7). It should be noted that, at all 
concentrations, the cytotoxicity of MWNT-g-PCA-PTX was 
slightly higher than for paclitaxel alone (n = 3, P , 0.05). 
For example, at 5 nM, the cytotoxicity of MWNT-g-PCA-
PTX was 13.3% higher than free paclitaxel in SKOV3 cells 
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at 96 hours of incubation time (Figure 7C). Moreover, the 
MWNT-g-PCA had no significant effect on cell viability at 
each incubation time, suggesting that the cytotoxicity was 
caused by the conjugated paclitaxel only. The calculated IC50 s 
for paclitaxel and the MWNT-g-PCA-PTX conjugate are 
summarized in Table 1.
Discussion
Due to the three-dimensional structure of paclitaxel in 
which aromatic rings are not in a plane, there is not a 
strong noncovalent or π-π interaction between paclitaxel 
and   carbon nanotubes, as well as doxorubicin.11,20 Although 
some research groups have reported physically loading of 
  paclitaxel on CNTs-g-PEG in a saturated methanolic solu-
tion of paclitaxel using sonication,31 in our study paclitaxel 
was covalently attached to the surface of MWNTs. Poly 
citric acid was chosen as a spacer to conjugate paclitaxel 
on the surface of MWNTs. Poly citric acid is a highly 
hydrophilic polymer that decreases the hydrophobicity of 
MWNTs. Poly citric acid is also a highly functional polymer 
with a large number of carboxylic functional groups that 
confer MWNTs with a high loading capacity. Moreover, 
poly citric acid is a highly biocompatible polymer.32,33 
Results of infrared,  1H NMR, and  13C NMR confirmed 
  conjugation of paclitaxel to the carboxyl functional groups 
of the poly citric acid branches on the surface of MWNTs 
via a   cleavable ester bond.
The size of a MWNT-g-PCA-PTX was about 207 nm, 
showing that MWNTs were not in their extended   conformation, 
given that the length of MWNTs is known to be more than 
several hundred nanometers. Due to the hydrophobicity of 
MWNTs and hydrophilicity of poly citric acid in aqueous 
solutions, poly citric acid branches surrounding MWNTs 
causing conformational changes to curved nanotubes; thus, 
their size was much smaller than expected. In order to confirm 
the dynamic light scattering results, the morphology and size 
of the conjugated nanotubes were further investigated using 
atomic force microscopy and transmission electron micros-
copy. Atomic force microscopy images of MWNT-g-PCA 
and MWNT-g-PCA-PTX did not show a linear or extended 
structure for MWNTs. As mentioned previously, due to the 
high hydrophobicity of MWNTs and high hydrophilicity of 
poly citric acid, and in order to decrease interactions between 
MWNTs and water molecules, it appears that MWNT-g-PCA 
in aqueous solution adapts a conformation whereby carbon 
nanotubes have the lowest interaction with the solvent. When 
these forms of nanoparticles reacted with the hydrophobic 
drug, paclitaxel, molecular self-assembly was still retained. 
Solvent evaporation, occurring during sample preparation 
for atomic force microscopy and transmission electron 
microscopy   imaging, caused the aggregation of conjugated 
nanotubes, which produced larger nanoparticles. Thus, graft-
ing poly citric acid on the surface of MWNTs not only raised 
their water   solubility and ability to be processed, but also 
changed their conformation toward new nanostructures for 
desired applications. As reported earlier in a similar study, the 
noncovalent interactions between   polyglycerol and MWNTs 
changed the conformation of MWNTs from a linear toward 
a circular type.34
Figure  4  Transmission  electron  microscopy  images  of  MWNT-g-PcA-PTX 
conjugates. 
Abbreviations: MWNT, multiwalled carbon nanotube; PcA, poly citric acid; PTX, 
paclitaxel.
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Drug content of paclitaxel in the MWNT-g-PCA-PTX 
conjugates was high enough to release an anticancer drug 
in the acidic environment of tumor cells and lysosomes. 
It seems that steric hindrance of hyperbranched poly 
citric acid decreased the rate of release in degradation. 
Similar results are reported in the literature when pacli-
taxel was conjugated to macromolecules or polymers 
via ester bonds. Chemical degradation of ester bonds to 
release paclitaxel was performed at a slow rate in various 
pH levels.35–37 In addition, hydrolysis of ester bonds to 
release paclitaxel from the conjugate form takes place 
via both chemical and enzymatic mechanisms. Thus, the 
esterase enzymes in the in vivo systems, especially in   
the lysosomes, will improve release of paclitaxel from the 
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functionalized MWNTs through enzymatic hydrolysis in 
the tumor cells.
Cytotoxicity studies showed that MWNT-g-PCA-PTX 
conjugates exhibited a more cytotoxic effect in comparison 
with free drug, particularly during shorter time incubations. 
Due to slow release of paclitaxel from the MWNT-g-PCA-
PTX conjugate, at the proposed concentration, the amount 
of free drug in MWNT-g-PCA-PTX was much lower than 
that of free paclitaxel. Thus, the improved cytotoxic effect 
on the cancer cell lines may be due to higher cell penetration 
Table 1 Ic50s (nM) of paclitaxel and conjugated MWNT-g-PcA-PTX against A549 and SKOV3 cell lines at different incubation times
Incubation time  
(hours)
A549 A549 SKOV3 SKOV3
PTX Conj PTX Conj
24 .2000* .2000 .2000 .2000
48 .200 26.365 ± 2.685 .2000 .2000
96 6.686 ± 0.665 2.621 ± 0.165 4.211 ± 0.335 1.385 ± 0.074
120 2.063 ± 0.162 ,1** 2.006 ± 0.096 ,1
Notes: Data are presented as means ± standard deviations (n = 3). *Ic50s were obtained by extrapolation if the nonlinear regression was more than 2000 or 200 nM; **Ic50s 
in this incubation time was smaller than the lowest concentration used (1 nM). 
Abbreviations: PTX, paclitaxel; conj, conjugate; MWNT, multiwalled carbon nanotubes; PcA, poly citric acid.
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of the conjugated nanotubes. This behavior could be related to 
amphiphilicity of the MWNT-g-PCA for improved cell wall 
interaction compared with absolute hydrophobic paclitaxel, 
the unique conformation of the conjugated nanotubes, or the 
carbon nanotube-based nanocarrier, which can penetrate into 
various cells.1,38
Nanoparticles can escape from the vasculature through 
the leaky endothelial tissue that surrounds the tumor and 
then accumulate in certain solid tumors by the so-called 
enhanced permeation and retention effect.39 When paclitaxel 
is conjugated to MWNT-g-PCA nanohybrids, it can reach the 
tumor site via an enhanced permeability and retention effect. 
According to increased cell penetration, it can be considered 
that to reach a similar effect of drug, a much lower dose 
of MWNT-g-PCA-PTX than the commercial formulations 
of paclitaxel can be used. Decreasing the anticancer dose 
is highly favorable for lowering toxic side effects of drug 
therapy to the normal organs and tissues.
Conclusion
In this study, MWNT-g-PCA was synthesized and used as a 
carrier for the anticancer drug, paclitaxel. During function-
alization of MWNTs with poly citric acid, the conformation 
of the nanotubes changed from a linear toward a circular 
type. The release of paclitaxel from the MWNT-g-PCA-PTX 
conjugates at pH 6.8 and 5.0 was higher than at pH 7.4, which 
was suitable for the release of the drug in tumor tissues and 
tumor cells. Results of cytotoxicity assays demonstrated 
that MWNT-g-PCA-PTX exhibited a higher cytotoxic 
effect compared with unconjugated paclitaxel, which may 
be due to increased cell penetration. Based on these results, 
it can be concluded that the conjugation of paclitaxel to 
MWNT-g-PCA is an effective delivery system for cancer 
chemotherapy.
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Figure S1 Infrared spectra of the A) oxidized MWNTs, B) MWNT-g-PcA, C) PTX, and D) MWNT-g-PcA-PTX conjugates containing 40% w/w PTX. 
Abbreviations: MWNT, multiwalled carbon nanotube; PcA, poly citric acid; PTX, paclitaxel.
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